Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
Masafumi OnoYoshinobu OnumaHideyuki KawashimaHironori HaraPatrick W SerruysRutao WangNeil O'LearyEdouard BenitLuc JanssensMaurizio FerrarioAleksander ŻurakowskiMarcello DominiciKurt HuberPaweł BuszmanScot GargJoanna J WykrzykowskaJan J PiekPeter JüniChristian HammStephan WindeckerPascal VranckxEfthymios N DeliargyrisDeepak L BhattRobert F StoreyMarco ValgimigliPatrick W J C Serruysnull nullPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
URL: https://clinicaltrials.gov.
Keyphrases
- percutaneous coronary intervention
- antiplatelet therapy
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- study protocol
- phase iii
- low dose
- cardiovascular events
- clinical trial
- phase ii
- atrial fibrillation
- coronary artery bypass
- heart failure
- randomized controlled trial
- type diabetes
- cardiovascular disease
- anti inflammatory drugs
- left ventricular
- double blind